2019.09.18 2019亚太生物医药合作峰会告示之路演集锦

clinical data from a Phase II clinical trial in Non-small cell lung cancer... cancer, lung cancer and in ovarian cancer. The China development activities

2008.11.18 Arthroscopic and Minimally Invasive SurgicalTechniques of the Hand and Wrist

of the hand andwrist after injury. The treatment of Scaphoid nonunionincluding

2017.06.04 ［ASCO 现场］ASCO Highlight：免疫治疗与靶向治疗仍是 2017 热点

lung cancer (NSCLC) with EGFR-activating mutation (ADJUVANT): A randomized, Phase III trial (CTONG 1104). First Author: Yi-Long Wu, Guangdong Lung Cancer

2018.01.24 挫败一线两花旦 奥西替尼成功跻身肺癌靶向一线

EGFR-Mutated Advanced Non-Small-Cell Lung Cancer.N Engl J Med.2018 378(2):113-125.本文

2018.01.24 权威解读: 肺癌筛查的利与弊

://health.clevelandclinic.org/2017/10/lung-cancer-screening-do-you-know-the-benefits-and-risks/https://www.cancer.org/latest-news/who-should-be-screened-for-lung-cancer.html作者简介:Gloria Zhang, MD, MPH.本文由微信公众号「同语轩」授权

2017.09.30 非小细胞肺癌治疗出现耐药？这样做…

众所周知， 肺癌是目前世界上发病率和死亡率最高的恶性肿瘤。根据生物学特性，肺癌可分为小细胞肺癌（small cell lung cancer，SCLC）和非小细胞肺癌（non-small cell lung cancer，NSCLC），前者占肺癌发病的 15%～25%，后者占肺癌发病的 80%～85%。驱动

2015.05.18 AME丛书 | 名家云集《肺癌》中英文版发布会

://v.qq.com/page/k/6/p/k0153ccji6p.html《肺癌》（Lung Cancer）一书由赫捷院士、Rafael Rosell教授、钟南山院士担任荣誉主编... Wakelee教授、Calvin S.H.教授、梁文华博士担任副主编的《肺癌》（Lung Cancer）一书在本次会议正式发布，该书邀请了12个国家、229名优秀专家参与

2017.09.27 「传承创新，携手同行」：CSCO 2017 盛大开幕

T790M-Positive Lung Cancer」研究，获得「CSCO 临床肿瘤学年度成就奖」。学术委员会从投稿中遴选 3 项具有代表性的研究，作为全体大会论文报告，分别为：秦叔逵... of Advanced EGFR+ Non-Small-Cell Lung Cancer (NSCLC) in Chinese Patients (ARCHER